| DESCRIPTION | - ALFTHAN et al., Protein Eng., (19950000), vol. 8, pages 725 - 731 | - |
| DESCRIPTION | - "Antibodies For Drug Delivery", HELLSTROM et al., Controlled Drug Delivery, Marcel Dekker, Inc., (19870000), pages 623 - 53 | - |
| DESCRIPTION | - ANUMULA, Anal. Biochem., (20060000), vol. 350, no. 1, page 1 | - |
| DESCRIPTION | - ARNOLD et al., J. Biol. Chem., (20050000), vol. 280, pages 29080 - 29087 | - |
| DESCRIPTION | - BITTNER et al., Methods in Enzymol., (19870000), vol. 153, pages 516 - 544 | - |
| DESCRIPTION | - BRINKMAN et al., J. Immunol. Methods, (19950000), vol. 182, pages 41 - 50 | - |
| DESCRIPTION | - "Carbohydrate Analysis", TOWNSEND, R.R., High Performance Liquid Chromatography and Capillary Electrophoresis, (19950000), pages 181 - 209 | - |
| DESCRIPTION | - CHASIN et al., Som. Cell Molec. Genet., (19860000), vol. 12, pages 555 - 556 | - |
| DESCRIPTION | - DNA Cloning: A Practical Approach, (19850000), vol. I and II | - |
| DESCRIPTION | - EDMONDS et al., Mol. Biotech., (20060000), vol. 34, pages 179 - 190 | - |
| DESCRIPTION | - GRAHAM et al., J. Gen. Virol., (19770000), vol. 36, page 59 | - |
| DESCRIPTION | - G. URLAUB; L.A. CHASIN, Proc. Natl. Acad. Sci., (19800000), vol. 77, pages 4216 - 4220 | - |
| DESCRIPTION | - HALLEWELL et al., J. Biol. Chem., (19890000), vol. 264, pages 5260 - 5268 | - |
| DESCRIPTION | - JEFFERIS et al., Immunol. Rev., (19980000), vol. 163, pages 59 - 76 | - |
| DESCRIPTION | - JEFFERIS, Nature Reviews, (20090000), vol. 8, pages 226 - 234 | - |
| DESCRIPTION | - KLEIN et al., Anal. Biochem., (19890000), vol. 179, page 162 | - |
| DESCRIPTION | - KOLKEKAR et al., Biochem., (19970000), vol. 36, pages 10901 - 10909 | - |
| DESCRIPTION | - KUSANO et al., Planta, (20080000), vol. 228, pages 367 - 381 | - |
| DESCRIPTION | - L.H. GRAF; L.A. CHASIN, Molec. Cell. Biol., (19820000), vol. 2, pages 93 - 96 | - |
| DESCRIPTION | - LOGAN et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 8, pages 355 - 359 | - |
| DESCRIPTION | - MATHER, Ann. NY Acad. Sci., (19820000), vol. 383, pages 44 - 68 | - |
| DESCRIPTION | - MATHER, Biol. Reprod., (19800000), vol. 23, pages 243 - 251 | - |
| DESCRIPTION | - MATTU et al., J. Biol. Chem., (19980000), vol. 273, pages 2260 - 2272 | - |
| DESCRIPTION | - "Monoclonal Antibodies For Immunotargeting Of Drugs In Cancer Therapy", ARNON et al., Monoclonal Antibodies And Cancer Therapy, Alan R. Liss, Inc., (19850000), pages 243 - 56 | - |
| DESCRIPTION | - MORRISON, Science, (19850000), vol. 229, page 1202 | - |
| DESCRIPTION | - NETTLETON et al., Int. Arch. Allergy Immunol., (19950000), vol. 107, pages 328 - 329 | - |
| DESCRIPTION | - PICHLER et al., Biotechnol. Bioeng., (20110000), vol. 108, pages 386 - 94 | - |
| DESCRIPTION | - SEGAL et al., J. Immunol. Methods, (20010000), vol. 248, pages 1 - 6 | - |
| DESCRIPTION | - SRINIVAS et al., J. Pharm. Sci., (19960000), vol. 85, no. 1, pages 1 - 4 | - |
| DESCRIPTION | - SRINIVAS et al., Pharm. Res., (19970000), vol. 14, no. 7, pages 911 - 6 | - |
| DESCRIPTION | - TUTT et al., J. Immunol., (19910000), vol. 147, page 60 | - |
| DESCRIPTION | - URLAUB; CHASIN, Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, page 4216 | - |
| DESCRIPTION | - WARD et al., Nature, (19890000), vol. 341, pages 544 - 546 | - |
| DESCRIPTION | - WEINER et al., J. Pharm. Biomed. Anal., (19970000), vol. 15, no. 5, pages 571 - 9 | - |
| DESCRIPTION | - WILSON et al., Cell, (19840000), vol. 37, page 767 | - |
| DESCRIPTION | - WRIGHT et al., Trends Biotech, (19970000), vol. 15, pages 26 - 32 | - |
| INTERNATIONAL-SEARCH-REPORT | - GREC O ET AL., "Influence of spermine on intestinal maturation of the glycoprotein glycosylation process in neonatal rats", BIOCHEM. J., (20000101), vol. 345, no. 1, doi:10.1042/BJ3450069, pages 69 - 75, XP055286196 | |
| INTERNATIONAL-SEARCH-REPORT | - HOSSLER ET AL., "Optimal and consistent protein glycosylation in mammalian cell culture.", GLYCOBIOLOGY., (20090901), vol. 19, no. 9, doi:10.1093/GLYCOB/CWP079, pages 936 - 949, XP055112498 | |
| INTERNATIONAL-SEARCH-REPORT | - BIOL-N'GARAGBA ET AL., "Polyamine participation in the maturation of glycoprotein fucosylation, but not siatylation, in rat small intestine.", PEDIATR RES., (20020101), vol. 51, no. 5, doi:10.1203/00006450-200205000-00014, pages 625 - 634, XP055286193 | |
| OPPOSITION | - AHMED Elsayed, "Application of hidrocyclone for cell separation in mammalian cell perfusion cultures", PhD thesis, Universität Carolo Wihelmina, (20050909), URL: https://d-nb.info/977727440/34, XP055616993 | - |
| OPPOSITION | - Cell Culture Catalogue BioConcept, (20040000), pages 1 - 82, XP055617042 | - |
| OPPOSITION | - CHENG et al., "Mucin biosynthesis. Characterization of UDP-galactose: alpha-N-acetylgalactosaminide beta 3 galactosyltransferase from human tracheal epithelium.", The Journal of Biological Chemistry, (19820610), vol. 257, no. 11, pages 6251 - 6258, XP055617006 | - |
| OPPOSITION | - FERNANDES, "Demonstrating Comparability of Antibody Glycosylation during Biomanufacturing", European Biopharamceutical Review, (20050000), pages 106 - 110, XP002738481 | - |
| OPPOSITION | - FROUD et al., "Polyamine enhanced product espression from transformed and recombinant cell lines", FROUD et al., Spier et al., PRODUCTION OF BIOLOGICALS FROM ANIMAL CELLS IN CULTURE, (19910000), pages 107 - 109, XP055454149 | - |
| OPPOSITION | - Froud Stephen J., "Polyamine enhanced product expression from transformed and recombinant cell lines", Production of biologicals from animal cells in culture, (19900000), pages 107 - 109, XP055454149 | - |
| OPPOSITION | - GOOCHEE et al., "Environment effects on protein glycosylation", Bio/Technology, (19900500), vol. 8, pages 421 - 427, XP055616997 | - |
| OPPOSITION | - HOSSLER P., "Protein Glycosylation Control in Mammalian Cell Culture: Past Precedents and Contemporary Prospects", Adv Biochem Engin/Biotechnol., (20120000), vol. 127, pages 187 - 219 | - |
| OPPOSITION | - HOSSLER, P., "Protein Glycosylation Control in Mammalian Cell Culture: Past Precedents and Contemporary Prospects", Adv. Biochem. Engin./Biotechnol., (20120000), vol. 127, pages 187 - 219 | - |
| OPPOSITION | - James D Crawley et al., "Enzymes and Proteins Containing Manganese: An Overview", James D Crawley et al., Sigel et al., METAL IONS IN BIOLOGICAL SYSTEMS, MARCEL DEKKER, INC., (20000000), vol. 37, pages 209 - 278, XP055335086 | - |
| OPPOSITION | - Kathrin Baumeister, "Prozessentwicklung zur Produktion von Erythropoietin mit Fibrosarcomzelle", PhD thesis, Universität Carolo Wihelmina, (20070510), XP055616986 | - |
| OPPOSITION | - KUMAR et al., "Elucidation of N-linked oligosaccharide structures of recombinant human Factor VIII using fluorophoreassisted carbohydrate electrophoresis", Biotechnology & Applied, (19961200), vol. 24, no. 3, pages 207 - 216, XP002421222 | - |
| OPPOSITION | - LAI et al., "Structural characterization of human erythropoietin.", The Journal of Biological Chemistry, (19850305), vol. 261, no. 7, pages 3116 - 3121, XP000857434 | - |
| OPPOSITION | - Lonza, "Advancing research with biologically relevant solutions", Catalog 2011-2012, (20100000), pages i-iv, 101 - 102, XP055616956 | - |
| OPPOSITION | - Lonza, "Advancing research with biologically relevant solutions", Catalog 2018, (20170000), pages 3-9, 142 - 143, XP055616961 | - |
| OPPOSITION | - MCCAMISH, "FDA ACPS-CP Update on Biosimilars", FDA White Oaks Conference, (20120808), pages 1 - 40, XP055615810 | - |
| OPPOSITION | - MÜTHING et al., "Effects of Buffering Conditions and Culture pH on Production Rates and Glycosylation of Clinical Phase I Anti-melanoma Mouse lgG3 Monoclonal Antibody R24", Biotechnology and Bioengineering, (20030805), vol. 83, no. 3, pages 321 - 334, XP009131808 | - |
| OPPOSITION | - NAVARATNAM et al., "Cationic activ&tion of galactosyltransf erase from rat mammary Golgi membranes by polyamines and by basic peptides and proteins", Biochemical Journal, (19860000), vol. 239, pages 423 - 433, XP055617004 | - |
| OPPOSITION | - "Nutrient Mixture F-12 Ham Formulation", URL: https://www.sigmaaldrich.com/life-science/cell-culture/learning-center/media-formulations/f-12-ham.printerview.html | - |
| OPPOSITION | - NYBERG GB . et al., "Metabolic effects on recombinant interferongamma glycosylation in continuous culture of Chinese hamster ovary cells", Biotechnol Bioeng., (19990205), vol. 62, no. 3, pages 336 - 347, XP055615714 | - |
| OPPOSITION | - Pamela Stanley et al.,, "Chapter 8 - N-Glycans", Pamela Stanley et al.,, VARKI A. et al., Essentials of Glycobiology, Second Edition, New York, Cold Spring Harbor Laboratory Press, (20090000), pages 2pp, 101 - 115, XP055616273 | - |
| OPPOSITION | - RAJU TS., "Glycosylation Variations with Expression Systems and Their Impact on Biological Activity of Therapeutic Immunoglobulins", BioProcess International, (20030400), vol. 1, no. 4, pages 44 - 55, XP002738482 | - |
| OPPOSITION | - SPELLMAN et al., The Journal of Biological Chemistry, (19890825), vol. 264, no. 24, pages 14100 - 14111, XP001196986 | - |
| OPPOSITION | - Stefan Nahrgang, "Influence of cell-line and process conditions on the glycosylation of Recombinant proteins", THÈSE NO 2608 (2002), ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE, (20030402), XP055179143 | - |
| OPPOSITION | - "THE EFFECT OF CELL CULTURE PARAMETERS ON PROTEIN GLYCOSYLATION", RESTELLI et al., Cell Engineering, Kluwer Academic Publishers, (20020000), vol. 3, pages 61 - 92, XP001203473 | - |
| OPPOSITION | - WONG DCF et al., "Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures", Biotechnol Bioeng., vol. 89, pages 164 - 177, XP009142862 | - |
| OPPOSITION | - Arvind Rajpal et al.,, "Introduction: Antibody Structure and Function", Arvind Rajpal et al.,, Steven M. Chamow et al.,, Therapeutic Fc-Fusion Proteins, First Edition, Wiley-VCH Verlag GmbH & Co.KGaA, (2014), pages 1 - 43, XP055198075 | |
| OPPOSITION | - TRUMMER et al., "Process parameter shifting: Part II. Biphasic cultivation—A tool for enhancing the volumetric productivity of batch processes using Epo‐Fc expressing CHO cells", Biotechnology and Bioengineering, (20060530), vol. 94, no. 6, pages 1045 - 1052, XP002651719 | |
| OPPOSITION | - CROWELL et al., "Amino Acid and Manganese Supplementation Modulates the Glycosylation State of Erythropoietin in a CHO Culture System", Biotechnology and Bioengineering, (200702), vol. 96, no. 3, pages 538 - 549, XP002454615 | |
| OPPOSITION | - EON-DUVAL A. et al., "Quality Attributes of Recombinant Therapeutic Proteins: An Assessment of Impact on Safety and Efficacy as Part of a Quality by Design Development Approach", Biotechnol. Prog., (20120000), vol. 28, no. 3, doi:10.1002/btpr.1548, pages 608 - 622, XP055318586 | |
| OPPOSITION | - EON-DUVAL et al., "Quality attributes of recombinant therapeutic proteins: An assessment of impact on safety and efficacy as part of a quality by design development approach", Biotechnol. Prog., (20120000), vol. 28, pages 608 - 622, XP055318586 | |
| OPPOSITION | - LIU et al., Biotechnology Progress, (201709), vol. 33, no. 5, pages 1173 - 1181, XP055617008 | |
| OPPOSITION | - JIMENEZ DEL VAL I. et al., "Towards the Implementation of Quality by Design to the Production of Therapeutic Monoclonal Antibodies with Desired Glycosylation Patterns", Biotechnol. Prog., (20101100), vol. 26, no. 6, page 6, XP055615705 | |
| OPPOSITION | - Patrick H C Van Berkel; et al.,, "N-linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG", Biotechnology Progress,, (2009), vol. 25, no. 1, pages 244 - 251, XP055043452 | |
| OPPOSITION | - HUANG et al., "Development of Super-CHO protein-free medium based on a statistical design", J ournal of Chemical Technology and Biotechnology, (20070000), vol. 82, doi:10.1002/jctb.1670, pages 431 - 441, XP055305242 | |
| OPPOSITION | - STADLMANN J. et al., "Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides", Proteomics, (20080000), vol. 8, doi:10.1002/pmic.200700968, pages 2858 - 2871, XP055188198 | |
| OPPOSITION | - Xuejun Gu; Liangzhi Xie; Bryan J Harmon; Daniel I C Wang, "Influence of Primatone RL supplementation on sialylation of recombinant human interferon-γ produced by Chinese hamster ovary cell culture using serum-free media", Biotechnology and Bioengineering,, (19971120), vol. 56, no. 4, pages 353 - 360, XP055005426 | |
| OPPOSITION | - GOLDMAN M et al., "Monitoring recombinant human interferon-gamma N-glycosylation during perfused fluidized-bed and stirred-tank batch culture of CHO cells", Biotechnology and Bioengineering, (19980000), vol. 60, no. 5, pages 596 - 607, XP002353272 | |
| OPPOSITION | - "Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry", J ANIN-BUSSAT et al., Glycosylation engineering of biopharmaceuticals : methods and protocols IN: Methods in molecular biology, Springer, (20130101), vol. 988, pages 93 - 113, ISBN 978-1-62703-326-8-93, XP009187102 | |
| OPPOSITION | - KEEN et al., "DEVELOPMENT OF A SERUM-FREE CULTURE MEDIUM FOR THE LARGE SCALE PRODUCTION OF RECOMBINANT PROTEIN FROM A CHINESE HAMSTER OVARY CELL LINE", Cytotechnology, (19950000), vol. 17, pages 153 - 163, XP008077215 | |
| OPPOSITION | - KEEN et al., "THE USE OF SERUM-FREE MEDIUM FOR THE PRODUCTION OF FUNCTIONALLY ACTIVE HUMANISED MONOCLONAL ANTIBODY FROM NS0 MOUSE MYELOMA CELLS ENGINEERED USING GLUTAMINE SYNTHETASE AS A SELECTABLE MARKER", Cytotechnology, (19960000), vol. 18, pages 207 - 217, XP009037180 | |
| OPPOSITION | - BUTLER M. et al., "Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems", Cytotechnology, (20060000), vol. 50, doi:10.1007/s10616-005-4537-x, pages 57 - 76, XP019393897 | |
| OPPOSITION | - ZHANG et al., "Characterization and Semiquantitative Analysis of Volatile Compounds in Orange Juice by Use of Headspace-Solvent Microextraction and Gas Chromatography", Cytotechnology, (201205), vol. 65, no. 3, pages 363 - 378, XP055615804 | |
| OPPOSITION | - ZHANG et al., "Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody", Cytotechnology, (20130000), vol. 65, pages 363 - 378, XP055615804 | |
| OPPOSITION | - ZHANG et al., "Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody", Cytotechnology, (2013), vol. 65, pages 363 - 378, XP055615804 | |
| OPPOSITION | - KIM, E. J. et al., "Development of a Serum-Free Medium for the Production of Humanized Antibody from Chinese Hamster Ovary Cells Using a Statistical Design", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY. ANIMAL, (19980000), vol. 34, pages 757 - 761, XP055314431 | |
| OPPOSITION | - KIM et al., "Development of a Serum-Free Medium for the Production of Humanized Antibody from Chinese Hamster Ovary Cells Using a Statistical Design", In vitro Cell. Dev. Biol, (19980000), vol. 34, pages 757 - 761, XP055314431 | |
| OPPOSITION | - KIM et al., "Development of a Serum-Free Medium for the Production of Humanized Antibody from Chinese Hamster Ovary Cells Using a Statistical Design", In Vitro Cell Dev. Biol. - Animal, (19980000), vol. 34, pages 757 - 761, XP055314431 | |
| OPPOSITION | - KIM et al., "Development of a Serum-Free Medium for the Production of Humanized Antibody from Chinese Hamster Ovary Cells Using a Statistical Design", In Vitro Cell. Dev. Biol. - Animal, (19980000), vol. 34, pages 757 - 761, XP055314431 | |
| OPPOSITION | - KIM et al., "Development of a Serum-Free Medium for the Production of Humanized Antibody from Chinese Hamster Ovary Cells Using a Statistical Design", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY - ANIMAL, (19981100), vol. 34, pages 757 - 761, XP055314431 | |
| OPPOSITION | - LIU et al., "Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab", BioDrugs, (20160800), vol. 30, no. 4, pages 321 - 338, XP055615807 | |
| OPPOSITION | - BAKER et al., "Enhancement of UDP-Galactose: Mucin Galactosyltransferase Activity by Spermine", Archives of Biochemistry and Biophysics, (19740000), vol. 165, doi:10.1016/0003-9861(74)90287-2, pages 597 - 603, XP024756884 | |
| OPPOSITION | - BAKER et al., "Enhancement of UDP-galactose:Mucin galactosyltransferase activity by spermine", Archives of Biochemistry and Biophysics, (197412), vol. 165, no. 2, doi:10.1016/0003-9861(74)90287-2, pages 597 - 603, XP024756884 | |
| OPPOSITION | - DULBECCO et al., "Plaque production by the polyoma virus", Virology, (19590700), vol. 8, no. 3, pages 396 - 397, XP023051822 | |
| OPPOSITION | - LUND et al., Molecular Immunology, (19930600), vol. 30, no. 8, pages 741 - 748, XP023788904 | |
| OPPOSITION | - AMAND et al., "Towards online control of glycosylation in mabs", Cortona Conference, (20100921), URL: http://www.ifpac.com/cortona/Cortona10-Presentations/St.Amand.pdf, XP055615684 | |
| OPPOSITION | - LLOP, E. et al., "Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo)", Analytical Biochemistry, (20080000), vol. 383, no. 2, pages 243 - 254, XP025585790 | |
| OPPOSITION | - DUROCHER et al., "Expression systems for therapeutic glycoprotein production", Current Opinion in Biotechnology, (20091104), vol. 20, no. 6, pages 700 - 707, XP026778881 | |
| OPPOSITION | - BECK et al., "Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells", Journal of Chromatography, vol. 819, doi:10.1016/j.jchromb.2004.06.052, pages 203 - 218, XP004838690 | |
| OPPOSITION | - NIWA et al., "IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides", Journal of Immunological Methods, (20050922), vol. 306, no. 1-2, pages 151 - 160, XP002696790 | |
| OPPOSITION | - JEFFERIS R., "Glycosylation of recombinant antibody therapeutics", Biotechnology Progress, (20050100), vol. 21, no. 1, pages 11 - 16, XP002456627 | |
| OPPOSITION | - CHEN et al., "A low-cost chemically defined protein free medium for a recombinant CHO cell line producing prothrombin", Biotechnol. Lett., (20000000), vol. 22, pages 837 - 841, XP002509008 | |
| OPPOSITION | - JAYME et al., "Basal medium development for serum-free culture: a historical perspective", Cytotechnology, (19970100), vol. 23, no. 1-3, pages 95 - 101, XP055305255 | |
| OPPOSITION | - JENKINS et al., "Getting the glycosylation right: implications for the biotechnology dustry", Nature Biotechnology, (19960800), vol. 14, no. 8, pages 975 - 981, XP002133654 | |
| OPPOSITION | - JEFFERIS, "Glycosylation as a strategy to improve antibody-based therapeutics", Nature Reviews Drug Discovery, (20090300), vol. 8, pages 226 - 234, XP002600969 | |
| OPPOSITION | - JEFFERIS J. et al., "Glycosylation as a strategy to improve antibody-based therapeutics", Nature Reviews Drug Discovery, (20090000), vol. 8, doi:10.1038/NRD2804, pages 226 - 234, XP002600969 | |
| OPPOSITION | - FALCK, D. et al., "Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation", Scientific Reports, (20170000), vol. 7, pages 1 - 10, XP055616290 | |
| OPPOSITION | - SERRATO et al., "Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media", Biotechnol. Appl. Biochem., (20070000), vol. 47, doi:10.1042/ba20060216, pages 113 - 124, XP002716095 | |
| OPPOSITION | - SERRATO et al., "Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media", Biotechnology & Applied, (2007), vol. 47, pages 113 - 124, XP002716095 | |
| OPPOSITION | - HAM, "CLONAL GROWTH OF MAMMALIAN CELLS IN A CHEMICALLY DEFINED, SYNTHETIC MEDIUM", Proceedings of the National Academy of Sciences of the United States of America, (19650200), vol. 53, no. 2, doi:10.1073/pnas.53.2.288, pages 288 - 293, XP001344705 | |
| OPPOSITION | - HAM R. G., "CLONAL GROWTH OF MAMMALIAN CELLS IN A CHEMICALLY DEFINED, SYNTHETIC MEDIUM", PNAS, (19650200), vol. 53, no. 2, pages 288 - 293, XP008058010 | |
| OPPOSITION | - SHIELDS et al., "Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcgammaRIII and antibody-dependent cellular toxicity", The Journal of Biological Chemistry, (20020000), vol. 277, no. 30, pages 26733 - 26740, XP002442140 | |
| OPPOSITION | - S HIELDS R. L. et al., "Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity", The Journal of Biological Chemistry, (20020000), vol. 277, no. 30, pages 26733 - 26740, XP002442140 | |
| OPPOSITION | - GOH et al., "Impact of the host cell line choice on glycan profile", Critical Reviews in Technology, (20180000), vol. 38, no. 6, pages 851 - 867, XP055617047 | |
| OPPOSITION | - VAN DEN STEEN P. et al., "Concepts and Principles of O-Linked Glycosylation", Critical Reviews in Biochemistry and Molecular Biology, (19980000), vol. 33, no. 3, doi:10.1080/10409239891204198, pages 151 - 208, XP009077473 | |
| OPPOSITION | - RAJU TS. et al., "Species-specific variation in glycosylation of IgG: evidence for species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics", Glycobiology, (200001), vol. 10, no. 5, pages 477 - 486, XP002964086 | |
| OPPOSITION | - LIFELY et al., "Glycosylation and biological-activity of CAMPATH-1H expressed in different cell-lines and grown under different culture conditions", Glycobiology, (19950000), vol. 5, no. 8, pages 812 - 822, XP002096118 | |
| OPPOSITION | - LIFELY MR et al., "Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions", Glycobiology, (19950000), vol. 5, doi:10.1093/glycob/5.8.813, pages 813 - 822, XP002096118 | |
| OPPOSITION | - GERVAIS, A. et al., "Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency", Glycobiology, (20030000), vol. 13, no. 3, pages 179 - 189, XP055616295 | |
| OPPOSITION | - BOLT et al., "OSTTRANSLATIONAL N-GLYCOSYLATION TAKES PLACE DURING THE NORMAL PROCESSING OF HUMAN COAGULATION FACTOR VII", Glycobiology, (200505), vol. 15, no. 5, pages 541 - 547, XP009061442 | |
| OPPOSITION | - HOSSLER et al., "Optimal and consistent protein glycosylation in mammalian cell culture", Glycobiology, (20090000), vol. 19, no. 9, pages 936 - 949, XP055112498 | |
| OPPOSITION | - HOSSLER et al., "Optimal and consistent protein glycosylation in mammalian cell culture", Glycobiology, (20090603), vol. 19, no. 9, pages 936 - 949, XP055112498 | |
| OPPOSITION | - HOSSLER P et al., "Optimal and consistent protein glycosylation in mammalian cell culture", Glycobiology, (20090000), vol. 19, no. 9, pages 936 - 949, XP055112498 | |
| OPPOSITION | - HOSSLER P., "Optimal and consistent protein glycosylation in mammalian cell culture", Glycobiology, (20090000), vol. 19, no. 9, doi:10.1093/glycob/cwp079, pages 936 - 949, XP055112498 | |
| OPPOSITION | - GOETZE et al., "- High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans", Glycobiology, (20110318), vol. 21, no. 7, pages 949 - 959, XP002736310 | |
| OPPOSITION | - CANIS et al., "In-depth comparison of N-glycosylation of human plasmaderived factor VIII and different recombinant products: from structure to clinical implications", Journal of Thrombosis and Haemostasis, (20180800), vol. 16, no. 8, pages 1592 - 1603, XP055616969 | |
| OPPOSITION | - EAGLE H., "AMINO ACID METABOLISM IN MAMMALIAN CELL CULTURES", Science, (19590821), vol. 130, pages 432 - 437, XP009016476 | |
| OPPOSITION | - ARNOLD et al., "The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins", Annu. Rev. Immunol., (20070000), vol. 25, doi:10.1146/annurev.immunol.25.022106.141702, pages 21 - 50, XP008081152 | |
| OPPOSITION | - ZHOU et al., "N-Glycans of ADAMTS 13 modulate its secretion and von Willebrand factor cleaving activity", Blood, (20090122), vol. 113, no. 4, pages 929 - 935, XP055616925 | |
| OPPOSITION | - BIOL-N'GARAGBA et al., "Polyamine Participation in the Maturation of Glycoprotein Fucosylation, but not Sialylation, in Rat Small Intestine", Pediatric Research, (20020000), vol. 51, no. 5, pages 625 - 634, XP055286193 | |
| OPPOSITION | - BIOL-N'GARAGBA et al., "Polyamine Participation in the Maturation of Glycoprotein Fucosylation, but not Sialylation, in Rat Small Intestine", Pediatric Research, (20020501), vol. 51, no. 5, pages 625 - 634, XP055286193 | |
| OPPOSITION | - Marie-Claire Biol-N'garagba; Greco Sandrine; George Pascal; Hugueny Irène; Louisot Pierre, "Polyamine participation in the maturation of glycoprotein fucosylation, but not sialylation, in rat small intestine", Pediatric Research,, (20020101), vol. 51, no. 5, pages 625 - 634, XP055286193 | |
| OPPOSITION | - BROOKS S., "Appropriate Glycosylation of Recombinant Proteins for Human Use Implications of Choice of Expression System", Molecular Biotechnology, (20040000), vol. 28, doi:10.1385/MB:28:3:241, pages 241 - 255, XP009091792 | |
| OPPOSITION | - HANISCH FG., "O-Glycosylation of the Mucin Type", Biol. Chem., (20010200), vol. 382, no. 2, pages 143 - 149, XP055615690 | |
| OPPOSITION | - RAJU et al., "Galactosylation variations in marketed therapeutic antibodies", Jordan , mAbs, (20120426), vol. 4, no. 3, pages 385 - 391, XP055138140 | |
| OPPOSITION | - RAJU et al., "Galactosylation variations in marketed therapeutic antibodies", mAbs, (20120000), vol. 4, no. 3, doi:10.4161/mabs.19868, pages 385 - 391, XP055138140 | |
| OPPOSITION | - RAJU et al., "Galactosylation variations in marketed therapeutic antibodies", Mabs, (20120000), vol. 4, no. 3, pages 385 - 391, XP055138140 | |
| OPPOSITION | - RAJU et al., "Galactosylation variations in marketed therapeutic antibodies", mAbs, (20120500), vol. 4, no. 3, pages 385 - 391, XP055138140 | |
| OPPOSITION | - RAJU, T. S. et al., "Galactosylation variations in marketed therapeutic antibodies", mAbs, (20120000), vol. 4, no. 3, pages 385 - 391, XP055138140 | |
| OPPOSITION | - TAN et al., "Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products", mAbs, (20120000), vol. 4, no. 6, pages 761 - 774, XP055285200 | |
| SEARCH | - IGARASHI K ET AL, "Modulation of cellular function by polyamines", INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, PERGAMON, GB, vol. 42, no. 1, doi:10.1016/J.BIOCEL.2009.07.009, ISSN 1357-2725, (20100101), pages 39 - 51, (20090728), XP026909603 [A] 1-11 | |
| SEARCH | - JEFFERIS ROY, "Glycosylation as a strategy to improve antibody-based therapeutics", NATURE REVIEWS. DRUG DISCOVERY, NATURE PUBLISHING GROUP, GB, (20090301), vol. 8, no. 3, doi:10.1038/NRD2804, ISSN 1474-1784, pages 226 - 234, XP002600969 [A] 1-11 * the whole document * | |
